314 related articles for article (PubMed ID: 17519851)
1. [Hashimoto's thyroiditis and autoimmunity parameters: descriptive study].
Fiducia M; Lauretta R; Lunghi R; Kyanvash S; Pallotti S
Minerva Med; 2007 Apr; 98(2):95-9. PubMed ID: 17519851
[TBL] [Abstract][Full Text] [Related]
2. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves' disease and Hashimoto's thyroiditis patients.
Pedro AB; Romaldini JH; Americo C; Takei K
Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):35-8. PubMed ID: 16450315
[TBL] [Abstract][Full Text] [Related]
3. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
Tektonidou MG; Anapliotou M; Vlachoyiannopoulos P; Moutsopoulos HM
Ann Rheum Dis; 2004 Sep; 63(9):1159-61. PubMed ID: 15308528
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis.
Li Y; Bai Y; Liu Z; Ozaki T; Taniguchi E; Mori I; Nagayama K; Nakamura H; Kakudo K
Pathol Int; 2009 Sep; 59(9):636-41. PubMed ID: 19712131
[TBL] [Abstract][Full Text] [Related]
5. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
6. [Changes in markers of autoimmunity in patients with Hashimoto thyroiditis treated with intravenous immunoglobulins. Preliminary results].
Antonelli A; Alberti B; Melosi A; Saracino A; Agostini S; Gambuzza C; Neri S; Baschieri L
Clin Ter; 1992 Sep; 141(9 Pt 2):37-42. PubMed ID: 1468196
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations].
Montes Santiago J; Gambón Deza F; García García MJ; González Vázquez L; Hermo Brión JA; Pérez Alvarez R
An Med Interna; 2000 Jul; 17(7):343-6. PubMed ID: 10981329
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS).
Blitshteyn S
Lupus; 2015 Nov; 24(13):1364-9. PubMed ID: 26038344
[TBL] [Abstract][Full Text] [Related]
9. Natural antibody status in patients with Hashimoto's thyroiditis.
Jasani B; Ternynck T; Lazarus JH; Phillips DI; Avrameas S; Parkes AB
J Clin Lab Immunol; 1999; 51(1):9-20. PubMed ID: 11424741
[TBL] [Abstract][Full Text] [Related]
10. Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels.
Akinci B; Comlekci A; Yener S; Bayraktar F; Demir T; Ozcan MA; Yuksel F; Yesil S
Arch Med Res; 2008 May; 39(4):397-401. PubMed ID: 18375250
[TBL] [Abstract][Full Text] [Related]
11. Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset.
Vantelon JM; Godeau B; André C; Bierling P
Thromb Haemost; 2000 Jan; 83(1):42-5. PubMed ID: 10669152
[TBL] [Abstract][Full Text] [Related]
12. [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease].
Cho DH; Choi MS; Kim DH; Kim DY; Shim SG; Lee JH; Koh KC; Paik SW; Yoo BC; Rhee JC
Korean J Hepatol; 2005 Sep; 11(3):261-7. PubMed ID: 16177552
[TBL] [Abstract][Full Text] [Related]
13. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.
Gulez N; Karaca NE; Aksu G; Kutukculer N
Autoimmunity; 2009 Jan; 42(1):74-9. PubMed ID: 19127458
[TBL] [Abstract][Full Text] [Related]
14. The relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis.
Vural P; Degirmencioglu S; Erden S; Gelincik A
Int Immunopharmacol; 2009 Feb; 9(2):212-5. PubMed ID: 19028605
[TBL] [Abstract][Full Text] [Related]
15. [The frequency of CTLA-4 gene polymorphism at position 49 exon 1 in children with Hashimoto's thyroiditis].
Kucharska A; Wiśniewska A; Rymkiewicz-Kluczyńska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):163-6. PubMed ID: 17020648
[TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses.
Müssig K; Leyhe T; Holzmüller S; Klein R; Weinert C; Saur R; Klingberg S; Häring HU; Gallwitz B
Psychoneuroendocrinology; 2009 Sep; 34(8):1252-6. PubMed ID: 19375868
[TBL] [Abstract][Full Text] [Related]
17. Anti-perinuclear and rheumatoid factor in different forms of autoimmune thyroid disease.
Scherbaum WA; Youinou PY; Le Goff P; Bottazzo GF
Clin Exp Immunol; 1984 Mar; 55(3):516-8. PubMed ID: 6608424
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo.
Kakourou T; Kanaka-Gantenbein C; Papadopoulou A; Kaloumenou E; Chrousos GP
J Am Acad Dermatol; 2005 Aug; 53(2):220-3. PubMed ID: 16021113
[TBL] [Abstract][Full Text] [Related]
19. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
[TBL] [Abstract][Full Text] [Related]
20. [The surface CD152 (CTLA-4) expression on peripheral blood lymphocytes in children with Hashimoto's thyroiditis].
Kucharska A; Górska E; Popko K; Wasik M; Rymkiewicz-Kluczyńska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):167-70. PubMed ID: 17020649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
